Home › All Companies › ACH › Annual Report

ACCENDRA HEALTH INC/VA/ (ACH) — Annual Report

AI-Powered SEC Filing Analysis

← All ACH filings
Latest Annual Report Filed: 2026-02-20

Key Insights

  • Accendra Health reported strong revenue growth of 1.1% year-over-year, driven by increased sales in their wound care and diabetes product segments.
  • The company saw a decline in operating margins due to higher professional fees and IT strategic initiatives, which could impact profitability going forward.
  • Accendra has significant geographic concentration risk, with over 80% of revenue coming from just four states (CA, IL, NY, OR), making the business vulnerable to regional market changes.
Sentiment: Neutral Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-02-20. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for ACCENDRA HEALTH INC/VA/

Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.